Go to Samples
Eli Lilly and Co.
Jaypirca
100mg x 30 per package
Indications and Usage
JAYPIRCA® is a kinase inhibitor indicated for the treatment of
- Adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor. .
This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. - Adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two prior lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor. .
This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows
HOW IT WORKS
The easy way to access samples
Confirm EligibilitySamples are available for authorized US healthcare providers
Create Free AccountRequest, track, and manage samples from multiple brands
Get your SampleSamples shipped directly to your practice door
Want to check your eligibility to order samples?
WHO IS PRESCRIBERPOINT
Increasing patient access to medications they need
At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed
WHAT HCPS ARE SAYING
FAQs
All you need to know to order samples
Due to manufacturer restrictions, there are some limitations on the quantities of samples that can be included in each order. We're working on new functionality to let your practice place larger, batch orders.